Australia markets closed

Proteomics International Laboratories Ltd (PIQ.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.8800-0.0200 (-2.22%)
At close: 03:40PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 30.00%
S&P500 52-week change 322.55%
52-week high 31.3850
52-week low 30.7000
50-day moving average 30.9924
200-day moving average 30.9705

Share statistics

Avg vol (3-month) 334.89k
Avg vol (10-day) 347.88k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8105M
% held by insiders 130.96%
% held by institutions 16.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -194.61%
Operating margin (ttm)-636.67%

Management effectiveness

Return on assets (ttm)-49.23%
Return on equity (ttm)-97.26%

Income statement

Revenue (ttm)3.03M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-19.40%
Gross profit (ttm)N/A
EBITDA -5.65M
Net income avi to common (ttm)-5.9M
Diluted EPS (ttm)-0.0390
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.97M
Total cash per share (mrq)0.04
Total debt (mrq)46.39k
Total debt/equity (mrq)0.89%
Current ratio (mrq)4.34
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-5.19M
Levered free cash flow (ttm)-3.32M